Natriumchloride Aguettant (Sodium Chloride)

Sodium chloride, the active ingredient in Natriumchloride Aguettant, is an electrolyte presented as an intravenous solution for intravenous use. It is employed to restore sodium and chloride balance in patients requiring fluid replacement, electrolyte replenishment, or treatment of hyponatremia.

GNH USA supplies Natriumchloride Aguettant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product complies with EU pharmaceutical regulations and undergoes rigorous quality control to ensure safety and efficacy for clinical use.

Natriumchloride Aguettant, an intravenous electrolyte solution, is used in clinical situations that require restoration of extracellular fluid volume and sodium balance. - Fluid replacement: restores intravascular volume and maintains hemodynamic stability in patients with dehydration or blood loss. - Electrolyte replenishment: corrects deficits of sodium and chloride during surgery, trauma, or intensive care management. - Hyponatremia: raises serum sodium concentrations to safe levels in individuals with low sodium syndromes. - Pre‑operative preparation: supplies isotonic saline to optimize intravascular volume before anesthesia and surgery. - Post‑operative care: maintains fluid and electrolyte homeostasis during recovery after surgical procedures.

Intravenous sodium chloride may be associated with adverse reactions, ranging from mild infusion‑related events to serious systemic effects.

Common Side Effects: - Infusion site discomfort: mild pain, erythema, or irritation at the catheter insertion point. - Hypernatremia: elevated serum sodium levels when administered in excess. - Hyperchloremia: increased chloride concentration that may alter acid‑base balance. - Fluid overload: signs of edema or weight gain in patients with limited cardiac reserve.

Serious or Rare Side Effects: - Pulmonary edema: accumulation of fluid in the lungs causing respiratory distress. - Severe electrolyte imbalance: marked shifts leading to cardiac arrhythmias or seizures. - Anaphylactic reaction: rare hypersensitivity presenting with hypotension, rash, and airway compromise.

When using Natriumchloride Aguettant, clinicians should observe several precautionary measures to ensure patient safety. - Assess fluid status: evaluate volume overload risk before initiation. - Monitor electrolytes: check serum Na+ and Cl‑ levels regularly. - Renal function: adjust infusion in patients with impaired kidney function. - Cardiac conditions: use cautiously in heart failure or hypertension. - Compatibility: ensure solution is compatible with other IV drugs before mixing. - Store at ambient temperature: keep in original container, protect from light and moisture.

Natriumchloride Aguettant can interact with other agents that affect fluid and electrolyte balance.

Major Interactions (Avoid): - Hypertonic saline: concurrent use may cause severe hypernatremia. - Potassium chloride: combined administration can lead to hyperchloremic metabolic acidosis. - Loop diuretics: may exacerbate electrolyte disturbances if not monitored.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may increase risk of hyperkalemia when fluid shifts occur. - Corticosteroids: can augment sodium retention, requiring electrolyte monitoring. - Blood products: co‑administration may affect chloride balance.